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INTRODUCTION  
Few pharmaceuticals are not removed in conventional sewage treatment, among the most 
important of these in terms of high consumption volume are carbamazepine [Clara, 2005], 
clofibric acid [Clara et al., 2005; Kosjek et al., 2007] and diclofenac [Kosjek et al., 2007].  
It is known that the above mentioned three stable pharmaceuticals can be photo-degraded in 
surface waters by sunlight [Doll & Frimmel, 2003, Petrovic & Barceló, 2007]. This is likely 
the most important ultimate fate of non bio-degradable and non-sorbing pharmaceuticals. 
The UV-absorption spectra of carbamazepine and clofibric acid [Doll & Frimmel, 2003] 
shows that carbamazepine absorbs from 320 nm with a local maximum at 280 nm. Clofibric 
acid absorbs weakly between 300  240 and has a local maximum at 230 nm. Sunlight has 
very little intensity below 320 nm and even most sunlight below 400 nm is filtered by the 
atmosphere. UV lamps used e.g. for photo-chemicals reactions and disinfection of water can 
create a many fold more intensively illumination of water with a higher fractions of light 
having lower wavelengths thus potentially decreasing half lives of pharmaceuticals to the 
seconds time scale. 
The aim of this study was to investigate the removal efficiency of six pharmaceuticals by 
photo-degradation and the advanced oxidation process (AOP), UV/H2O2. The six 
pharmaceuticals were the four non-steroidal-anti-inflamatory drugs: ibuprofen, diclofenac, 
naproxen and ketoprofen, the pharmacological active metabolite of the lipid lowering agent, 
clofibrin, clofibric acid, and the anticonvulsant and mood stabilizing drug, carbamazepine.   
METHOD 
Treatment experiments were performed using a UV lamp optimized for photochemical 
treatment in a flow through set-up. For the AOP experiments 60 mg/L H2O2 was added to the 
water before treatment. Tap water and treated sewage were spiked with 10 µg/L of each of the 
pharmaceuticals. The treatment effectiveness is evaluated based on the Electrical Energy per 
Order (EEO) (unit kWh/m 3), which is defined as the electrical energy consumed per unit 
volume of water treated required for 90 % removal of the investigated compound [Bolton et 
al., 2001].   
RESULTS AND DISCUSSION 
It was found that four of the six pharmaceuticals were almost completely removed in tap 
water both by UV treatment and by the AOP with the lowest treatment dosis of UV applied in 
the experiment, making it difficult to determine the exact removal efficiency. The exception 
was ibuprofen and carbamazepine, which exhibited a relationship between UV dose and 
removal (figure 1). The EEO was determined to 22.7 kWh/m3 (UV) and 3.7 kWh/m3 
(UV/H2O2) for carbamazepine and 8.6 kWh/m3 (UV) and 3.7 kWh/m3 (UV/H2O2) for 
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ibuprofen (Table 1). However, all pharmaceuticals can be removed with UV treatment alone 
and therefore removal in wastewater was only tested by UV-treatment. 
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Figure 1: Energy effectiveness of removal of pharmaceuticals.  
In the wastewater effluent the removal by UV was almost complete for ketoprofen even at the 
lowest treatment effect, while the other compounds show dependency of energy/UV dose 
applied (Table 1, Figure 1).  
Table 1: Energy needed for reducing concentrations by one decade.   
Tap water Wastewater effluent 
 
UV UV/H2O2 UV 
EEO ± 95% CI EEO ± 95% CI EEO ± 95% CI 
Clofibric acid - 1.6a 5.5 ± 0.6 
Ibuprofen  8.6 ± 4.4 3.7 ± 0.7 33.4 ± 3.4 
Naproxen  2.1 ± 0.9 2.2a 9.6 ± 1.1 
Ketoprofen  - - 1.2 ± 0.3 
Diclofenac - - 2.0 ± 0.6 
Carbamazepine  22.7 ± 4.1 3.7a - 
a
 Regression with only two points. 
Ibuprofen is the compound that required the highest UV dose to remove 90 % from 
wastewater (EEO = 33.4 kWh/m3) where naproxen and clofibric acid required 9.6 kWh/m3 
and 5.5 kWh/m3, respectively. Ketoprofen and diclofenac needed considerable less energy 
than clofibric acid. Ibuprofen and naproxen are biodegradable and will be removed in 
biologically treated wastewater. Therefore the relevant estimate of the needed treatment is the 
energy use for removal of clofibric acid which required 5.5 kWh/m3 for 90 % removal.  
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